You’re not a failure

I endorse on two counts: 1. That Dock Health is breaking important ground by offering modern, well-designed tools for care teams to effectively collaborate around patients. 2. That Christina Farr and Marissa Moore assembled an incredible resource for virtual care creators.

Loved reading the story of Dr. Glaucomflecken, whose videos always make me laugh and never fail to make a thoughtful point.

The cost of oral anti-cancer drugs can have devastating effects on patients' financial well-being. Many policy opportunities exist! #cancercare nejm.org/doi/full/10.10…

This is an important #oncology #NLP study. We are finally starting to see NLP help accelerate true abstraction of key cancer concepts across the whole medical record. Kudos to the teams Microsoft and Providence St. Joseph's. arxiv.org/abs/2203.10442

Exciting to hear Eric J. Small, MD, FASCO discuss the importance of remote #symptom monitoring and management in people with #cancer. #ASCO22

How is it possible that a company needs 10 days to remove you from their marketing email list?! Would love to know what happens during each of those 10 days!

I love you Journal of Clinical Oncology, but when you tell me the ToC continues on the following page, please don't make me flip through 5 pages of ads before the following page! Am I right #OncTwitter? Or am I just dating myself because I read my Journal of Clinical Oncology on paper?

It's a sad, sad day.

Iris is now available for download in the Apple App Store and Google Play Store. Click here to discover more: buff.ly/3cOQoHj #IrisOncology #CancerCare #MomentsInBetween

I am really looking forward to next week's Nutrition by Diagnosis webinar for anyone interested in the interplay between diet and #ProstateCancer. This is the first in a terrific series the team at Iris Oncology has put together.

My pharmacy: We take #privacy and infection control super seriously. Also my pharmacy: Mr. Norden, we need you to literally shout your name and home address across this plexiglass #COVID19 barrier before we can give you your prescription.

Hope you will join us!

This is a really nice analysis of a really disappointingly poor “analysis.”

This is a brilliantly straightforward and unbiased analysis. Worthwhile for all to read, and IMO hard to quibble with any of the key points.

This is going to be a very informative virtual event. Please join the expert Iris team below!

Welcome Susan! Delighted to have you on the team!

In 2023, my #PCP's office messages me in the patient portal asking me to call and schedule. Which prompts an amazing business idea: electronic scheduling software...🤦🏻‍♂️ #healthTech

I became a #neurologist because of Marty. He was a consummate physician and human. And wow was he fun to be around! I will miss him so much.

Out now in JAMA Oncology, our viewpoint arguing for better evidence supporting new technologies in RT. The proton ship has sailed (in US), but we have window of opportunity to do the right studies for more recently debuted tech: adaptive RT, MR guided, etc jamanetwork.com/journals/jamao…